Company / Operating Margin
MADRIGAL PHARMACEUTICALS, INC. Operating Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-31.3%
FY2025
5-year range
-276.4% / -31.3%
FY2024-FY2025
Trend
+88.7%
vs FY2024
Sector context
#72 of 136
Health Care
What the data says
At -31.3%, MADRIGAL PHARMACEUTICALS, INC.'s operating margin ranks #72 of 136 in the Health Care sector.
Based on SEC 10-K filings.
-31.3% in FY2025.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#72 of 136 in Health CareTop 53% of 136This company -31.3% Sector average -778.9%
▼
+96.0% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 88.7% year-over-year.
- Currently 747.6pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -31.3% | +88.7% |
| FY2024 | -276.4% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026